Chemistry Wealth Management’s T. Rowe Price Capital Appreciation Equity ETF TCAF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.47M | Buy |
155,089
+12,562
| +9% | +$443K | 1.17% | 16 |
|
|
2025
Q1 | $4.6M | Buy |
142,527
+14,916
| +12% | +$481K | 1.07% | 18 |
|
|
2024
Q4 | $4.25M | Buy |
127,611
+17,251
| +16% | +$574K | 1% | 19 |
|
|
2024
Q3 | $3.67M | Buy |
110,360
+16,382
| +17% | +$545K | 0.87% | 21 |
|
|
2024
Q2 | $2.95M | Buy |
93,978
+35,498
| +61% | +$1.11M | 0.76% | 25 |
|
|
2024
Q1 | $1.77M | Buy |
58,480
+36,348
| +164% | +$1.1M | 0.48% | 39 |
|
|
2023
Q4 | $612K | Buy |
+22,132
| New | +$612K | 0.18% | 83 |
|